As artificial intelligence increasingly powers diagnostic tools, predictive analytics, and personalized treatment algorithms in healthcare, disputes involving these systems are becoming inevitable. A misdiagnosis by an AI-powered radiology system, a failure of an AI-driven surgical robot, or a breach of patient data privacy caused by a machine-learning model can trigger high-stakes disputes. When such disputes arise, the JAMS Artificial Intelligence Dispute Clause and Rules offer a specialized arbitration framework uniquely suited to the technical complexity and acute confidentiality demands of healthcare AI cases.
Why Healthcare AI Disputes Are Different
Disputes arising from AI use in healthcare typically involve:
Highly sensitive patient data protected by HIPAA.
Proprietary algorithms, training datasets, and model architectures that constitute valuable trade secrets.
Complex causation questions requiring deep technical expertise (e.g., was the AI’s output erroneous due to flawed training data, bias, or improper deployment?)
Urgent need for speed: patients, hospitals, and manufacturers often cannot afford multi-year litigation delays.
Traditional court litigation risks public disclosure of protected information and trade secrets, protracted “fishing expedition” discovery into black-box models, and judges or juries lacking the technical background to evaluate sophisticated AI evidence. Arbitration under the JAMS AI Rules directly addresses each of these pain points.
How the JAMS AI Rules Transform Arbitration Process
Automatic and Robust Confidentiality Protections
Unlike standard JAMS or AAA rules, Rule 26(b) of the JAMS AI Rules and the Model Protective Order impose strict confidentiality on all parties, counsel, and experts from the moment arbitration commences – no motion practice required. Patient PHI can be designated “Highly Confidential”; the developer’s source code, training datasets, and model weights are automatically shielded from public filing or competitor access. Such protections eliminate the greatest fear of both healthcare providers and AI vendors: that litigation itself will expose proprietary technology or trigger regulatory investigations.
Controlled, Expert-Only Inspection of the AI System (Rule 16.1(b))
The tribunal can order inspection of the actual AI system (hardware, software, model, training data) in a secure environment established by the disclosing party. Critically, materials cannot be copied or removed. A neutral AI forensics expert (preferably from JAMS’ forthcoming third-party expert list) can evaluate whether the model exhibited bias, overfitting, or data poisoning.
Focused and Time-Bound Discovery
Discovery requests must be “directly relevant” and “reasonably restricted” in scope, time, and custodians. Broad, boilerplate definitions are prohibited. Fact discovery closes 75 days after the preliminary conference; expert discovery 105 days. The hearing commences within 60 days of fact discovery cutoff (extensions allowed only for good cause). This prevents the endless, budget-breaking e-discovery battles that plague AI litigation in court.
Technical Expertise at the Helm
Parties can select (or the JAMS appointment process can prioritize) arbitrators with demonstrated AI, machine-learning, or healthcare-technology experience – something impossible with randomly assigned judges.
Potential Healthcare AI Dispute Scenarios Where the JAMS AI Rules May Apply
Example 1: A hospital licenses an AI-powered diagnostic imaging tool to detect early-stage cancers. A patient receives a false-negative result, delaying treatment and leading to advanced disease. The hospital commences an arbitration with the AI developer for breach of contract and product liability, alleging the algorithm was defective. The developer counters that the hospital provided poor-quality or insufficient training data during onboarding, or that clinicians misused the tool’s confidence scores.
JAMS AI Rules Advantages: Secure expert inspection of the model and training data, combined with the automatic protective order, allows the tribunal to pinpoint the true cause while fully protecting patient PHI and the developer’s intellectual property. The expedited timeline delivers certainty to both parties within months rather than years.
Example 2: A health system licenses its de-identified imaging dataset to an AI company for model training. The health system later discovers the vendor used the data to train models subsequently licensed to a direct competitor. The health system claims breach and seeks injunctive relief.
JAMS AI Rules Advantages: The Model Protective Order and Rule 16.1(b) inspection provisions allow forensic examination of training logs and model provenance without exposing the underlying patient images or the vendor’s full codebase.
These are just a few realistic “what-if” scenarios – the truth is, AI is now everywhere in healthcare, from drug discovery and robotic surgery to wearables, insurance scoring, and mental-health chatbots. The great thing about the JAMS AI Rules is that they handle them all the same smart way: everything stays confidential, real experts get safe access to the tech, and the case is over in months instead of years.
Practical Recommendation for Healthcare Businesses
Forward-thinking healthcare institutions and AI vendors are already inserting the JAMS AI Model Dispute Resolution Clause into licensing, SaaS, and development agreements. Pairing the clause with a tiered dispute resolution process (negotiation → mediation → binding arbitration) and a robust data-privacy exhibit maximizes protection.
Healthcare AI promises revolutionary advances in patient outcomes, but it also introduces novel liability and confidentiality risks. The JAMS Artificial Intelligence Dispute Rules provide a purpose-built forum that protects patients, preserves trade secrets, and delivers technically informed awards far faster than courts can. If you have questions about arbitration agreements, strategy, or representation in any complex matter, contact our healthcare attorneys at (212) 668-0200 or info@mdrxlaw.com.
